Transcriptome profiling of adipose tissue reveals depot-specific metabolic alterations among colorectal cancer patients.

CONTEXT Adipose tissue inflammation and dysregulated energy homeostasis are key mechanisms linking obesity and cancer. Distinct adipose tissue depots strongly differ in their metabolic profiles, however comprehensive studies of depot-specific perturbations among cancer patients are lacking. OBJECTIVE We compared transcriptome profiles of visceral (VAT) and subcutaneous (SAT) adipose tissue from colorectal cancer patients, and assessed the associations of different anthropometric measures with depot-specific gene expression. DESIGN Whole transcriptomes of VAT and SAT were measured in 233 patients from the ColoCare Study and visceral and subcutaneous fat area were quantified via computed tomography. RESULTS VAT compared to SAT showed elevated gene expression of cytokines, cell adhesion molecules and key regulators of metabolic homeostasis. Increased fat area was associated with downregulated lipid and small molecule metabolism and upregulated inflammatory pathways in both compartments. Comparing these patterns between depots proved specific and more pronounced gene expression alterations in SAT and identified unique associations of integrins and lipid metabolism-related enzymes. VAT gene expression patterns that were associated with visceral fat area poorly overlapped with patterns associated with self-reported body mass index (BMI). However, subcutaneous fat area and BMI showed similar associations with SAT gene expression. CONCLUSIONS This large-scale human study demonstrates pronounced disparities between distinct adipose tissue depots and reveals that BMI poorly correlates with fat mass-associated changes in VAT. Together, these results provide crucial evidence for the necessity to differentiate between distinct adipose tissue depots for a correct characterization of gene expression profiles that may affect metabolic health of colorectal cancer patients.

[1]  M. Migaldi,et al.  Radiotherapy-induced mesorectum alterations: histological evaluation of 90 consecutive cases , 2015, Scandinavian journal of gastroenterology.

[2]  G. Colditz,et al.  The Plausibility of Obesity Paradox in Cancer-Point. , 2018, Cancer research.

[3]  T. McLaughlin,et al.  Preferential fat deposition in subcutaneous versus visceral depots is associated with insulin sensitivity. , 2011, The Journal of clinical endocrinology and metabolism.

[4]  Michael J Thun,et al.  Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. , 2003, The New England journal of medicine.

[5]  J. Böhm,et al.  Body Fatness, Adipose Tissue Compartments, and Biomarkers of Inflammation and Angiogenesis in Colorectal Cancer: The ColoCare Study , 2018, Cancer Epidemiology, Biomarkers & Prevention.

[6]  P. Froguel,et al.  Tenomodulin is highly expressed in adipose tissue, increased in obesity, and down-regulated during diet-induced weight loss. , 2009, The Journal of clinical endocrinology and metabolism.

[7]  J. Murabito,et al.  Fat quality and incident cardiovascular disease, all-cause mortality, and cancer mortality. , 2015, The Journal of clinical endocrinology and metabolism.

[8]  C. Aguilar-Salinas,et al.  High adiponectin concentrations are associated with the metabolically healthy obese phenotype. , 2008, The Journal of clinical endocrinology and metabolism.

[9]  M. Leblanc,et al.  Association between Body Mass Index and Cancer Survival in a Pooled Analysis of 22 Clinical Trials , 2016, Cancer Epidemiology, Biomarkers & Prevention.

[10]  C. Ulrich,et al.  Effects of intermittent and continuous calorie restriction on body weight and metabolism over 50 wk: a randomized controlled trial. , 2018, The American journal of clinical nutrition.

[11]  Xin Wang,et al.  Bioinformatics Applications Note Systems Biology Htsanalyzer: an R/bioconductor Package for Integrated Network Analysis of High-throughput Screens , 2022 .

[12]  Dominique Scherer,et al.  Signals from the Adipose Microenvironment and the Obesity–Cancer Link—A Systematic Review , 2017, Cancer Prevention Research.

[13]  J. Vague,et al.  The degree of masculine differentiation of obesities: a factor determining predisposition to diabetes, atherosclerosis, gout, and uric calculous disease. , 1956, The American journal of clinical nutrition.

[14]  Y. Bossé,et al.  Gene expression variability in subcutaneous and omental adipose tissue of obese men. , 2007, Gene expression.

[15]  B. Caan,et al.  The Importance of Body Composition in Explaining the Overweight Paradox in Cancer-Counterpoint. , 2018, Cancer research.

[16]  T. Hudson,et al.  A survey of genes differentially expressed in subcutaneous and visceral adipose tissue in men. , 2004, Obesity research.

[17]  D. Loskutoff,et al.  Monocyte chemoattractant protein 1 in obesity and insulin resistance , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[18]  J. Després,et al.  Abdominal obesity and metabolic syndrome , 2006, Nature.

[19]  M. Gunter,et al.  Adiposity and gastrointestinal cancers: epidemiology, mechanisms and future directions , 2018, Nature Reviews Gastroenterology & Hepatology.

[20]  S. B. Pedersen,et al.  11β‐HSD Type 1 Expression in Human Adipose Tissue: Impact of Gender, Obesity, and Fat Localization , 2007, Obesity.

[21]  J. Böhm,et al.  The ColoCare Study: A Paradigm of Transdisciplinary Science in Colorectal Cancer Outcomes , 2018, Cancer Epidemiology, Biomarkers & Prevention.

[22]  Michael J. Thomas,et al.  SAA: a link between cholesterol efflux capacity and inflammation?1 , 2015, Journal of Lipid Research.

[23]  M. Caligiuri,et al.  Obesity, Inflammation, and Cancer. , 2016, Annual review of pathology.

[24]  E. Maury,et al.  Adipokines oversecreted by omental adipose tissue in human obesity. , 2007, American journal of physiology. Endocrinology and metabolism.

[25]  J. Stevens,et al.  Selection of measures in epidemiologic studies of the consequences of obesity , 2008, International Journal of Obesity.

[26]  E. Calle,et al.  Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms , 2004, Nature Reviews Cancer.

[27]  Petra C. Schwalie,et al.  Insights into negative regulation by the glucocorticoid receptor from genome-wide profiling of inflammatory cistromes. , 2013, Molecular cell.

[28]  M. Serlie,et al.  Obesity activates a program of lysosomal-dependent lipid metabolism in adipose tissue macrophages independently of classic activation. , 2013, Cell metabolism.

[29]  P. Schrotz-King,et al.  Inflammation- and angiogenesis-related biomarkers are correlated with cancer-related fatigue in colorectal cancer patients: Results from the ColoCare Study. , 2019, European journal of cancer care.

[30]  L. Lönn,et al.  The expression of NAD(P)H:quinone oxidoreductase 1 is high in human adipose tissue, reduced by weight loss, and correlates with adiposity, insulin sensitivity, and markers of liver dysfunction. , 2007, The Journal of clinical endocrinology and metabolism.

[31]  R Guardo,et al.  Quantification of adipose tissue by MRI: relationship with anthropometric variables. , 1992, Journal of applied physiology.

[32]  K. Fearon,et al.  The role of body composition evaluation by computerized tomography in determining colorectal cancer treatment outcomes: a systematic review. , 2015, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[33]  B. Caan,et al.  Visceral adiposity and cancer survival: a review of imaging studies , 2018, European journal of cancer care.

[34]  C. Bouchard,et al.  Clinical utility of visceral adipose tissue for the identification of cardiometabolic risk in white and African American adults. , 2013, The American journal of clinical nutrition.

[35]  L. Oyama,et al.  Peritumoural adipose tissue pro‐inflammatory cytokines are associated with tumoural growth factors in cancer cachexia patients , 2018, Journal of cachexia, sarcopenia and muscle.

[36]  A. Rossi,et al.  Morphological and Functional Changes in the Peritumoral Adipose Tissue of Colorectal Cancer Patients , 2017, Obesity.

[37]  C. Roberts,et al.  Depot-specific differences in inflammatory mediators and a role for NK cells and IFN-γ in inflammation in human adipose tissue , 2009, International Journal of Obesity.

[38]  C. Beglinger,et al.  Insulin resistance causes inflammation in adipose tissue , 2018, The Journal of clinical investigation.

[39]  E. Barrett-Connor,et al.  Insulin-like growth factor-I and cancer mortality in older men. , 2010, The Journal of clinical endocrinology and metabolism.

[40]  C. Fox,et al.  Association between single-slice measurements of visceral and abdominal subcutaneous adipose tissue with volumetric measurements: the Framingham Heart Study , 2010, International Journal of Obesity.

[41]  A. Saltiel,et al.  Adapting to obesity with adipose tissue inflammation , 2017, Nature Reviews Endocrinology.

[42]  Cheng Cheng,et al.  Sample size determination for the false discovery rate , 2005, Bioinform..

[43]  B. Ludvik,et al.  CC chemokine and CC chemokine receptor profiles in visceral and subcutaneous adipose tissue are altered in human obesity. , 2008, The Journal of clinical endocrinology and metabolism.

[44]  G. Rojo-Martínez,et al.  Altered Expression of miR-181a-5p and miR-23a-3p Is Associated With Obesity and TNF&agr;-Induced Insulin Resistance , 2018, The Journal of clinical endocrinology and metabolism.

[45]  Jürgen Böhm,et al.  Metabolomics and transcriptomics identify pathway differences between visceral and subcutaneous adipose tissue in colorectal cancer patients: the ColoCare study. , 2015, The American journal of clinical nutrition.

[46]  U. Nöthlings,et al.  Postdiagnosis body mass index and risk of mortality in colorectal cancer survivors: a prospective study and meta-analysis , 2014, Cancer Causes & Control.

[47]  Caroline S. Fox,et al.  The Framingham Heart Study — 67 years of discovery in metabolic disease , 2016, Nature Reviews Endocrinology.

[48]  M. Bauer,et al.  Glucocorticoid receptor dimerization is required for survival in septic shock via suppression of interleukin‐1 in macrophages , 2012, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[49]  Youyi Fong,et al.  Rank-based two-sample tests for paired data with missing values. , 2018, Biostatistics.

[50]  M. Prentki,et al.  Increased subcutaneous adipose tissue expression of genes involved in glycerolipid-fatty acid cycling in obese insulin-resistant versus -sensitive individuals. , 2014, The Journal of clinical endocrinology and metabolism.

[51]  G. Frühbeck,et al.  IL-32α-induced inflammation constitutes a link between obesity and colon cancer , 2017, Oncoimmunology.

[52]  Pablo Tamayo,et al.  Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[53]  R. Lehner,et al.  Chemotherapy diminishes lipid storage capacity of adipose tissue in a preclinical model of colon cancer , 2017, Lipids in Health and Disease.

[54]  U. Turpeinen,et al.  Estrogen Metabolism in Abdominal Subcutaneous and Visceral Adipose Tissue in Postmenopausal Women , 2017, The Journal of clinical endocrinology and metabolism.

[55]  S. B. Pedersen,et al.  Monocyte chemoattractant protein-1 release is higher in visceral than subcutaneous human adipose tissue (AT): implication of macrophages resident in the AT. , 2005, The Journal of clinical endocrinology and metabolism.

[56]  P. Schrotz-King,et al.  CT-based compartmental quantification of adipose tissue versus body metrics in colorectal cancer patients , 2016, European Radiology.

[57]  B. Spiegelman,et al.  Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. , 1993, Science.

[58]  P. Svensson,et al.  Expression of GHR and Downstream Signaling Genes in Human Adipose Tissue-Relation to Obesity and Weight Change. , 2018, The Journal of clinical endocrinology and metabolism.

[59]  J. Reynolds,et al.  Pro-inflammatory and tumour proliferative properties of excess visceral adipose tissue. , 2011, Cancer letters.

[60]  S. Holm A Simple Sequentially Rejective Multiple Test Procedure , 1979 .

[61]  I. Rogatsky,et al.  There goes the neighborhood: Assembly of transcriptional complexes during the regulation of metabolism and inflammation by the glucocorticoid receptor , 2016, Steroids.

[62]  K. Straif,et al.  Body Fatness and Cancer--Viewpoint of the IARC Working Group. , 2016, The New England journal of medicine.

[63]  A. Schafer,et al.  Subcutaneous Fat Fibrosis Links Obesity to Insulin Resistance in Chinese Americans , 2018, The Journal of clinical endocrinology and metabolism.

[64]  C. Fox,et al.  Association Between Visceral and Subcutaneous Adipose Depots and Incident Cardiovascular Disease Risk Factors , 2015, Circulation.

[65]  N. Abdella,et al.  Adiponectin, insulin resistance and clinical expression of the metabolic syndrome in patients with Type 2 diabetes , 2007, International Journal of Obesity.

[66]  J. Böhm,et al.  Associations Between Dietary Patterns and Longitudinal Quality of Life Changes in Colorectal Cancer Patients: The ColoCare Study , 2018, Nutrition and cancer.

[67]  M. Stumvoll,et al.  Macrophage infiltration into omental versus subcutaneous fat across different populations: effect of regional adiposity and the comorbidities of obesity. , 2007, The Journal of clinical endocrinology and metabolism.

[68]  N. Habermann,et al.  Gene Expression Changes in Adipose Tissue with Diet- and/or Exercise-Induced Weight Loss , 2013, Cancer Prevention Research.

[69]  D. Gozal,et al.  Metabolic dysfunction drives a mechanistically distinct proinflammatory phenotype in adipose tissue macrophages. , 2014, Cell metabolism.

[70]  J. Moreno-Navarrete,et al.  Decreased STAMP2 expression in association with visceral adipose tissue dysfunction. , 2011, The Journal of clinical endocrinology and metabolism.

[71]  S. Delorme,et al.  Validation of Anthropometric Indices of Adiposity against Whole-Body Magnetic Resonance Imaging – A Study within the German European Prospective Investigation into Cancer and Nutrition (EPIC) Cohorts , 2014, PloS one.

[72]  Wei Shi,et al.  BeadArray Expression Analysis Using Bioconductor , 2011, PLoS Comput. Biol..

[73]  C. Ulrich,et al.  Energy balance and gastrointestinal cancer: risk, interventions, outcomes and mechanisms , 2018, Nature Reviews Gastroenterology & Hepatology.

[74]  M. Desai,et al.  Obesity is associated with macrophage accumulation in adipose tissue. , 2003, The Journal of clinical investigation.

[75]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[76]  B. Lippitz,et al.  Cytokine patterns in cancer patients: A review of the correlation between interleukin 6 and prognosis , 2016, Oncoimmunology.

[77]  P. Stattin,et al.  Obesity and colon cancer: Does leptin provide a link? , 2004, International journal of cancer.

[78]  G. Bray,et al.  The Relationship of Waist Circumference and BMI to Visceral, Subcutaneous, and Total Body Fat: Sex and Race Differences , 2011, Obesity.

[79]  D. Brenner,et al.  A Systematic Review of the Effect of Lifestyle Interventions on Adipose Tissue Gene Expression: Implications for Carcinogenesis , 2017, Obesity.

[80]  C. Ulrich,et al.  Elevated biomarkers of inflammation are associated with reduced survival among breast cancer patients. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[81]  Udo Hoffmann,et al.  Body fat distribution, incident cardiovascular disease, cancer, and all-cause mortality. , 2013, Journal of the American College of Cardiology.

[82]  E. Wagner,et al.  A switch from white to brown fat increases energy expenditure in cancer-associated cachexia. , 2014, Cell metabolism.

[83]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[84]  R. Eils,et al.  Comparison of normalization methods for Illumina BeadChip HumanHT-12 v3 , 2010, BMC Genomics.

[85]  A. Sekerková,et al.  Human adipose tissue accumulation is associated with pro-inflammatory changes in subcutaneous rather than visceral adipose tissue , 2017, Nutrition & Diabetes.

[86]  Z. Kováčová,et al.  Worsening of obesity and metabolic status yields similar molecular adaptations in human subcutaneous and visceral adipose tissue: decreased metabolism and increased immune response. , 2010, Journal of Clinical Endocrinology and Metabolism.